Immunomodulatory Effects of Carob (Ceratonia siliqua) Extract in Pregnant Rats: A Histological Evaluation of Embryonic Liver
DOI:
https://doi.org/10.59167/srw0t384Keywords:
Ceratonia siliqua, Pregnancy, Embryonic Liver, Immunomodulation, Cytokines, Histology, PolyphenolsAbstract
Background: Carob (Ceratonia siliqua) is a polyphenol-containing plant that has anti-oxidant and anti-inflammatory qualities, which can affect maternal immunity in pregnancy. Nevertheless, it has not been studied how it affects maternal immunity and the integrity of embryonic organs. Objective. The current paper aimed to test the immunomodulatory properties of carob extract on pregnant rats affected with induced hepatitis and to examine the histological alterations of embryonic liver tissue. Methods: Pregnant female Wistar rats (200-230 g) were chosen randomly and distributed into four groups (n=7/group): control (vehicle only), carob-only (400mg/kg/day carob extract), infected (induced hepatitis by concanavalin A), and carob + infected (carob pretreatment then ConA induced hepatitis). Carob aqueous extract was administered on gestational days 12-18. At gestational day 19 (GD19), hepatic enzyme levels (ALT, AST, ALP, GGT) and pro-inflammatory cytokine levels (IL-6, IL-12, IL-18, IL-29, TNF-α) were assessed in maternal blood using ELISA. Cesarean delivery was used to harvest embryos, and embryonic livers were subjected to histological analysis using hematoxylin and eosin staining. Results: Pretreatment with carob significantly attenuated maternal hepatic infection by reducing ALT (345 ± 30 to 120 ± 20 U/L, 65%) and AST (290 ± 25 to 105 ± 18 U/L, 64%). There was a significant decrease in pro-inflammatory cytokines, namely, IL-6 (reduced by 62.5% [320 ± 50 to 120 ± 30 pg/mL, p < 0.01]), TNF-α (reduced by 63% [2500 ± 400 to 920 ± 150 pg/mL, p < 0.001]), IL-12 (reduced by 50% [110 ± 20 to 55 ± 10, p < 0.01]) and IL-18 (reduction by 55% [400 ± 50 to 180 ± 30 pg/mL, p < 0.01]). Embryonic livers of carob-treated dams were observed to have preserved hepatic architecture with visible central veins and ordered hepatocyte cords, but those of embryos of damaged dams that did not receive carotenogenic treatment had a significant structural disorganization, cellular necrosis, and architectural distortion. Conclusion: Carob extract has strong immunomodulatory activity in pregnant rats, suppressing inflammatory changes and hepatic damage, which is associated with the maintenance of embryonic liver architecture. These effects have not yet been verified in other models, and the mechanisms behind them remain unclear.References
[1] Mor, G., Cardenas, I. (2010) The immune system in pregnancy: a unique complexity, American Journal of Reproductive Immunology 63: 425-433.
[2] PrabhuDas, M., Bonney, E., Caron, K., Dey, S., Erlebacher, A., Fazleabas, A., Fisher, S., Golos, T., Matzuk, M., McCune, J.M. (2015) Immune mechanisms at the maternal-fetal interface: perspectives and challenges, Nature Immunology 16: 328-334.
[3] Hsiao, E.Y., Patterson, P.H. (2012) Placental regulation of maternal‐fetal interactions and brain development, Developmental Neurobiology 72: 1317-1326.
[4] Mahmoud, D.A., Saleh, S.S. (2021) Determination of the level of homocysteine and antioxidants in the blood serum of women with gestational diabetes, Solid State Technology 64: 1129-1135.
[5] Brenner, C., Galluzzi, L., Kepp, O., Kroemer, G. (2013) Decoding cell death signals in liver inflammation, Journal of Hepatology 59: 583-594.
[6] Pantham, P., Aye, I.L., Powell, T.L. (2015) Inflammation in maternal obesity and gestational diabetes mellitus, Placenta 36: 709-715.
[7] Crawford, L.W., Foley, J.F., Elmore, S.A. (2010) Histology Atlas of the Developing Mouse Hepatobiliary System with Emphasis on Embryonic Days 9.5-18.5, Toxicologic Pathology 38: 872-906.
[8] Ornoy, A., Reece, E.A., Pavlinkova, G., Kappen, C., Miller, R.K. (2015) Effect of maternal diabetes on the embryo, fetus, and children: congenital anomalies, genetic and epigenetic changes and developmental outcomes, Birth Defects Research Part C, Embryo Today: Reviews 105: 53-72.
[9] Biner, B., Gubbuk, H., Karhan, M., Aksu, M., Pekmezci, M. (2007) Sugar profiles of the pods of cultivated and wild types of carob bean (Ceratonia siliqua L.) in Turkey, Food Chemistry 100: 1453-1455.
[10] Papagiannopoulos, M., Wollseifen, H.R., Mellenthin, A., Haber, B., Galensa, R. (2004) Identification and quantification of polyphenols in Carob Fruits (Ceratonia siliqua L.) and derived products by HPLC-UV-ESI/MSn, Journal of Agricultural and Food Chemistry 52: 3784-3791.
[11] Goulas, V., Georgiou, E. (2019) Utilization of carob fruit as sources of phenolic compounds with antioxidant potential: Extraction optimization and application in food models, Foods 9: 20.
[12] Rahman, I., Biswas, S.K., Kirkham, P.A. (2006) Regulation of inflammation and redox signaling by dietary polyphenols, Biochemical Pharmacology 72: 1439-1452.
[13] Aboura, I., Nani, A., Belarbi, M., Murtaza, B., Fluckiger, A., Dumont, A., Benammar, C., Tounsi, M.S., Ghiringhelli, F., Rialland, M. (2017) Protective effects of polyphenol-rich infusions from carob (Ceratonia siliqua) leaves and cladodes of Opuntia ficus-indica against inflammation associated with diet-induced obesity and DSS-induced colitis in Swiss mice, Biomedicine & Pharmacotherapy 96: 1022-1035.
[14] Martić, N., Zahorec, J., Stilinović, N., Andrejić-Višnjić, B., Pavlić, B., Kladar, N., Šoronja-Simović, D., Šereš, Z., Vujčić, M., Horvat, O. (2022) Hepatoprotective effect of carob pulp flour (Ceratonia siliqua L.) extract obtained by optimized microwave-assisted extraction, Pharmaceutics 14: 657.
[15] Rašković, A., Martić, N., Tomas, A., Andrejić-Višnjić, B., Bosanac, M., Atanasković, M., Nemet, M., Popović, R., Krstić, M., Vukmirović, S. (2023) Carob extract (Ceratonia siliqua L.): Effects on dyslipidemia and obesity in a high-fat diet-fed rat model, Pharmaceutics 15: 2611.
[16] Ahmed, A.F., Cevher, Ş.C., Peker, E.G.G., Balabanlı, B., Ebegil, M. (2024) Synergistic effects of thymoquinone and carob powder versus dexamethasone in the model of asthma in pregnant rats: new insights into their therapeutic effects, Gazi Medical Journal 35: 393-400.
[17] Terry, K., Chatman, L., Foley, G., Kadyszewski, E., Fleeman, T., Hurtt, M., Chapin, R. (2005) Effects of feed restriction on fertility in female rats, Birth Defects Research Part B: Developmental and Reproductive Toxicology 74: 431-441.
[18] Custódio, L., Fernandes, E., Escapa, A.L., Fajardo, A., Aligué, R., Alberício, F., Neng, N.R., Nogueira, J.M.F., Romano, A. (2011) Antioxidant and cytotoxic activities of carob tree fruit pulps are strongly influenced by gender and cultivar, Journal of Agricultural and Food Chemistry 59: 7005-7012.
[19] EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010) Scientific Opinion on the substantiation of health claims related to pectins and reduction of post‐prandial glycaemic responses (ID 786), maintenance of normal blood cholesterol concentrations (ID 818) and increase in satiety leading to a reduction in energy intake (ID 4692) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006, European Food Safety Authority (EFSA Journal), 10; John Wiley & Sons, Hoboken, New Jersey, USA, https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2010.1747
[20] Si-Tayeb, K., Lemaigre, F.P., Duncan, S.A. (2010) Organogenesis and development of the liver, Developmental Cell 18: 175-189.
[21] Tiegs, G., Hentschel, J., Wendel, A. (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A, The Journal of Clinical Investigation 90: 196-203.
[22] Gorovits, B., Azadeh, M., Buchlis, G., Fiscella, M., Harrison, T., Havert, M., Janetzki, S., Jawa, V., Long, B., Mahnke, Y.D. (2023) Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy, An Official Journal of the American Association of Pharmaceutical Scientists (The AAPS Journal)) 25: 47.
[23] Bancroft, J.D., Gamble, M. (2008) Theory and Practice of Histological Techniques, 6th ed., Churchill Livingstone / Elsevier, Philadelphia, Pennsylvania, USA, pp. 725
[24] Gao, L., Zhao, Y.C., Liang, Y., Lin, X.H., Tan, Y.J., Wu, D.D., Li, X.Z., Ye, B.Z., Kong, F.Q., Sheng, J.Z. (2016) The impaired myocardial ischemic tolerance in adult offspring of diabetic pregnancy is restored by maternal melatonin treatment, Journal of Pineal Research 61: 340-352.
[25] Hasan, S., Junaid, F., Mahdi, B., Hussein, F. (2025) Therapeutic Applications of Medicinal Plants for the Treatment of Human Intestinal Diarrhea: Review Article, South Asian Journal of Life Sciences 13: 20-24.
[26] Stavrou, I.J., Christou, A., Kapnissi-Christodoulou, C.P. (2018) Polyphenols in carobs: A review on their composition, antioxidant capacity and cytotoxic effects, and health impact, Food Chemistry 269: 355-374.
[27] Koyama, Y., Brenner, D.A. (2017) Liver inflammation and fibrosis, The Journal of Clinical Investigation 127: 55-64.
[28] Schwabe, R.F., Brenner, D.A. (2006) Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways, American Journal of Physiology-Gastrointestinal and Liver Physiology 290: G583-G589.
[29] Al-Quraghuli, A.Z.K., Mahmood, D.A. (2025) Determination of high-sensitivity C-reactive protein in chronic kidney disease patients in Al-Hawija General Hospital in Kirkuk City-Iraq, International Journal of Biological and Pharmaceutical Sciences Archive 10: 173-187.
[30] Tilg, H., Moschen, A.R., Szabo, G. (2016) Interleukin‐1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, Hepatology 64: 955-965.
[31] Bachmann, M., Pfeilschifter, J., Mühl, H. (2018) A prominent role of interleukin-18 in acetaminophen-induced liver injury advocates its blockage for therapy of hepatic necroinflammation, Frontiers in Immunology 9: 161.
[32] Atta, A.H., Atta, S.A., Khattab, M.S., El-Aziz, T.H.A., Mouneir, S.M., Ibrahim, M.A., Nasr, S.M., Emam, S.R. (2023) Ceratonia siliqua pods (Carob) methanol extract alleviates doxorubicin-induced nephrotoxicity via antioxidant, anti-inflammatory and anti-apoptotic pathways in rats, Environmental Science and Pollution Research 30: 83421-83438.
[33] Robbins, J.R., Bakardjiev, A.I. (2012) Pathogens and the placental fortress, Current Opinion in Microbiology 15: 36-43.
[34] Dahlgren, J., Samuelsson, A.-M., Jansson, T., Holmäng, A. (2006) Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation, Pediatric Research 60: 147-151.
[35] Vanhees, K., Godschalk, R.W., Sanders, A., van Doorn, S.B.v.W., van Schooten, F.J. (2011) Maternal quercetin intake during pregnancy results in an adapted iron homeostasis at adulthood, Toxicology 290: 350-358.
[36] He, J., Cui, H., Shi, X., Jin, Q., Han, X., Han, T., Peng, J., Guo, S., Zhang, L., Zhao, Y. (2022) Functional hepatobiliary organoids recapitulate liver development and reveal essential drivers of hepatobiliary cell fate determination, Life Medicine 1: 345-358.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Zainab Hasan Majeed (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
From July 2025 onward, all TUJNAS publications are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This open license allows anyone to share (copy and redistribute) and adapt (remix, transform, and build upon) the work in any medium or format, for any purpose (even commercially), as long as appropriate credit is given to the original author(s) and source. This permissive framework encourages scholarly innovation, translation, and integration into wider academic outputs by removing unnecessary legal barriers. Users of TUJNAS content must provide proper attribution and indicate if any changes were made to the original work. By enabling unrestricted reuse, the CC BY 4.0 license maximizes the reach and impact of research findings while ensuring that authors receive full recognition for their work. (For complete legal details of the CC BY 4.0 license, please refer to the official Creative Commons website.)
Submissions (from July 2025 onward): By submitting a manuscript to TUJNAS for publication (Volume 10, Issue 2, 2025 and thereafter), authors confirm the following:
- Originality: The submission is original, has not been published elsewhere, and is not under consideration by another journal.
- Copyright Retention: The author(s) retain copyright of the work, but grant TUJNAS a non-exclusive right to publish, reproduce, distribute, and archive the article.
- Open Access License: Upon acceptance, the article will be published open access under the CC BY 4.0 license.
- Repository Deposit: The author(s) agree that the full text and metadata of the article may be deposited in digital archives or repositories, to facilitate indexing and reuse under the CC BY 4.0 license.
- Indexing and Sharing: The author(s) acknowledge that TUJNAS may make the article available to third-party indexing, abstracting, and discovery services under the CC BY 4.0 license, without the need for additional permission.
These submission terms ensure that authors understand and consent to the open-access, licensed nature of TUJNAS publications from the outset.